Rigenerand receives regulatory approval for gene therapy production

Authorisation has enabled Rigenerand to enter into clinic, offer CDMO services and consultancy, and plan to expand cleanroom capacity

picture of

Breaking News

R+D Custom Automation makes deal with SiO2 on coronavirus vials

The agreement accelerates the production of SiO2's patented plastic vials for storing novel coronavirus vaccines and ...

Symbiosis Pharmaceutical Services raises $1.25m

Scotland-based sterile manufacturing services provider has received finance from Allied Irish Bank (GB) to support its ...

Ziath delivers COVID-19 sample tracking packages

Two options for reliable tracking of patient samples are available

Increasing process consistency and data integrity in cell and gene therapies

Gene therapy, recognised as one of the most promising opportunities for the comprehensive and precise treatment of ...

BES completes viral vector suite for Cobra Biologics

Cobra has invested in upgrading part of its existing development and production facility with 3 viral vector suites to ...

Sexton partners on modular fill-finish for cell and gene therapies

Sexton Biotechnologies has partnered with BioSpherix to create a fully-enclosed, modular fill-finish system with rapid ...

A pivotal time for pharma's global biotechnology industry

In these uncertain times, GEA, the globally active mechanical and plant engineering company, is taking its role in the ...

Base Genomics launch raises $11m to commercialise epigenetic technology

Base Genomics has plans to use epigenetic technology for early and sensitive detection of cancer from liquid biopsy

UK vaccine manufacturing nonprofit signs first industry partnership

Oxford Biomedica will be collaborating with VMIC to enable scaled-up manufacture of viral vector-based vaccines

Optimising gene therapy for now and the future

With multiple gene therapies currently approved for use in the US, dozens in pivotal trials and hundreds more in ...

Medical cannabis made in Italy

Dr Fabio Di Francesco, a compounding pharmacist based in Rome, describes how cannabis is used in various dosage forms ...

New technology in cell and gene therapies to meet patient needs

Angela Myers, Head of Gene Editing and Novel Modalities at Merck, outlines the challenges arising with the increasing ...

Catalent acquires Japanese facility to provide local and global clinical supply solutions

Purchase will establish a new clinical GMP manufacturing and distribution hub to support clinical studies

Orgenesis launches cell-based vaccine platform targeting SARS-CoV-2

US biotech has created a cell-based vaccine platform targeting solid tumours for use against viral diseases